Another clinical trial performed in 2011 by Rastelli et al. showed that aromatase inhibitor-induced musculoskeletal symptoms in breast cancer can be reduced using 4 months of treatment with vitamin D2. The gene discussed is CYP19A1; the disease is breast cancer.